GLENMARK PHARMACEUTICALS EUROPE LIMITED

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2026	4	Value not published	4
2025	1	Value not published	1
2024	4	Value not published	4
2023	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierGLENMARK PHARMACEUTICALS EUROPE LIMITED

Source records

Published awards

Page 1 of 2 · 31 records.

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
Buyer: NHS England
End date in notice
30 Apr 2029
Value shown in notice
£1,241,520,444Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60 / ocds-b5fd17-1063d704-a8da-4ec0-b11c-5b9fec849d60-1
NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 2 Hospital Only products
Buyer: NHS England

GLENMARK PHARMACEUTICALS EUROPE LIMITED

Published records by year

Buyer relationships by value counted

Published awards

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender

NHS National Generics Pharmaceuticals - Supply Chain Resilience Lot 2 Hospital Only products

Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products

NHS National Branded Interim - 1 June 2026

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)

NHS National Framework for Transition products commencing 1 October 2024

NHS National Framework for Transition products commencing 1 May 2024

NHS National Generic Pharmaceuticals Wave 14b

Generic, Branded Generic & Proprietary Medicinal Products - Group 18

Range of Generic Cancer Medicines (single supplier)

Icatibant Solution for Injection

Direct Acting Oral Anticoagulants (DOACs)

All Other Cardiovascular & Respiratory Medicines

Branded and Branded Generic Inhalers

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Wave 15b - Hospital Only DCE & DSW regions

Sapropterin & Deferasirox Tablets